News
News

enGene announces appointment of Theresa Podrebarac, MD, as Chief Medical Officer

in portfolio news

enGene Inc. announced today that Theresa Podrebarac, MD, has joined the company as Chief Medical Officer. In her new position, Dr. Podrebarac will be responsible for designing and executing clinical development plan for enGene’s pipeline of products, as well as effectively positioning these novel therapeutics in the marketplace.

Subscribe